Covaxin, Covishield trial participants to get vaccination certificate via Co-WIN App

Published On 2021-08-24 03:30 GMT | Update On 2021-08-24 12:28 GMT

New Delhi: The clinical trial participants of Covishield and Covaxin will be issued vaccination certificate through Co-WIN app, Union Health Minister Mansukh Mandaviya announced on Monday.

"In a welcome initiative, digital #COVID19 vaccination certificates will now be issued to the clinical trial participants of COVISHIELD & COVAXIN through Co-WIN. The nation thanks them for their incredible commitment & contribution to COVID-19 vaccine research & treatment," he said in a tweet.

The Indian Council of Medical Research (ICMR), in partnership with the Serum Institute of India (SII), had conducted Phase 2/3 bridging studies of Covishield from August 2020. The Phase 3 efficacy clinical trials for Covaxin were also conducted by Bharat Biotech International Ltd (BBIL) from November 2020.

The Health Minister said that the participants can download their individual certificates through the Co-WIN portal, Aarogya Setu, Digilocker or the UMANG application.

The ICMR was designated by the Union Health Ministry as the nodal agency for collection of vaccination data for such participants, and had provided the data for 11,349 such persons to the Ministry.

The digital vaccination certificate will be issued to the participants who were administered the vaccines during these trials or studies, or even after the trials and studies.

Article Source : IANS

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

MD Bureau

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Covaxin, Covishield trial participants to get vaccination certificate via Co-WIN App

Similar News

USFDA inspection: Aurobindo Pharma receives 8 observations for Unit-XII

USFDA issues 4 observations for Zydus Jarod injectable manufacturing plant

Lupin gets 2 USFDA observations for Aurangabad facility

ICMR licenses nine breakthrough health technologies to industry partners including Biological E, Zydus

Granules India, NIPER SAS Nagar inaugurate Centre of Excellence for Sustainable Pharma Innovation

SC Drops Criminal Charges Against P&G Director, But No Relief For Akums Drugs in Vicks Gel Case

DPIIT collaborate with Pfizer to strengthen India healthcare innovation ecosystem

Zydus Lifesciences names Nitin D Parekh as President (Special Projects)